99 related articles for article (PubMed ID: 16711753)
61. Sulfated Glycans in HIV Infection and Therapy.
Pomin VH; Bezerra FF; Soares PAG
Curr Pharm Des; 2017; 23(23):3405-3414. PubMed ID: 28137224
[TBL] [Abstract][Full Text] [Related]
62. Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques.
Oliviero G; Stornaiuolo M; D'Atri V; Nici F; Yousif AM; D'Errico S; Piccialli G; Mayol L; Novellino E; Marinelli L; Grieco P; Carotenuto A; Noppen S; Liekens S; Balzarini J; Borbone N
Anal Chem; 2016 Feb; 88(4):2327-34. PubMed ID: 26810800
[TBL] [Abstract][Full Text] [Related]
63. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120.
Augustin LA; Fantini J; Mootoo DR
Bioorg Med Chem; 2006 Feb; 14(4):1182-8. PubMed ID: 16216516
[TBL] [Abstract][Full Text] [Related]
64. [Computer modeling of the promising inhibitors of the HIV-1 subtype A replication as a framework for the rational anti-aids drug design].
Andrianov AM; Anishchenko IV
Biomed Khim; 2011; 57(2):161-73. PubMed ID: 21870601
[TBL] [Abstract][Full Text] [Related]
65. The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1.
Tan S; Li JQ; Cheng H; Li Z; Lan Y; Zhang TT; Yang ZC; Li W; Qi T; Qiu YR; Chen Z; Li L; Liu SW
J Biol Chem; 2019 Sep; 294(37):13740-13754. PubMed ID: 31346035
[TBL] [Abstract][Full Text] [Related]
66. CD4 down-modulating compounds with potent anti-HIV activity.
Vermeire K; Schols D; Bell TW
Curr Pharm Des; 2004; 10(15):1795-803. PubMed ID: 15180541
[TBL] [Abstract][Full Text] [Related]
67. The anti-HIV-1 activity of chloroquine.
Savarino A; Gennero L; Sperber K; Boelaert JR
J Clin Virol; 2001 Feb; 20(3):131-5. PubMed ID: 11166661
[TBL] [Abstract][Full Text] [Related]
68. Sepharose-bound, highly sulfated glycosaminoglycans can capture HIV-1 from culture medium.
Curatella B; Bartolini B; Di Caro A; Cavallaro RA; Liverani L; Mascellani G; Benedetto A; Castilletti C; Capobianchi MR; Cellai L
Carbohydr Res; 2005 Mar; 340(4):759-64. PubMed ID: 15721350
[TBL] [Abstract][Full Text] [Related]
69. Substances may help women.
AIDS Patient Care STDS; 1999 Jul; 13(7):442. PubMed ID: 10870608
[No Abstract] [Full Text] [Related]
70. Identification of anti-HIV components of salivary agglutinin (SAG).
Chow BE
Penn Dent J (Phila); 2002; 102():11. PubMed ID: 15487554
[No Abstract] [Full Text] [Related]
71. Computer-Aided Approaches for Targeting HIVgp41.
Allen WJ; Rizzo RC
Biology (Basel); 2012 Aug; 1(2):311-38. PubMed ID: 23730525
[TBL] [Abstract][Full Text] [Related]
72. ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block fusion-active gp41 core formation.
González-Ortega E; Mena MP; Permanyer M; Ballana E; Clotet B; Esté JA
Antimicrob Agents Chemother; 2010 Oct; 54(10):4487-92. PubMed ID: 20643898
[TBL] [Abstract][Full Text] [Related]
73. ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formation.
Wang H; Qi Z; Guo A; Mao Q; Lu H; An X; Xia C; Li X; Debnath AK; Wu S; Liu S; Jiang S
Antimicrob Agents Chemother; 2009 Dec; 53(12):4987-98. PubMed ID: 19786602
[TBL] [Abstract][Full Text] [Related]
74. Specific CD4 down-modulating compounds with potent anti-HIV activity.
Vermeire K; Schols D
J Leukoc Biol; 2003 Nov; 74(5):667-75. PubMed ID: 12960237
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of HIV entry by carbohydrate-binding proteins.
Balzarini J
Antiviral Res; 2006 Sep; 71(2-3):237-47. PubMed ID: 16569440
[TBL] [Abstract][Full Text] [Related]
76. A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activity.
Manetti F; Tintori C; Armand-Ugón M; Clotet-Codina I; Massa S; Ragno R; Esté JA; Botta M
J Chem Inf Model; 2006; 46(3):1344-51. PubMed ID: 16711753
[TBL] [Abstract][Full Text] [Related]
77. The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.
Armand-Ugón M; Clotet-Codina I; Tintori C; Manetti F; Clotet B; Botta M; Esté JA
Virology; 2005 Dec; 343(1):141-9. PubMed ID: 16168454
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
